DMVM Drugs Private Limited
About DMVM Drugs Private Limited
Data last updated:
DMVM Drugs Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24297DL2019PTC356003.
The company has an authorised share capital of ₹2.25 Cr and a paid-up capital of ₹2.21 Cr. It is led by directors Molina Dev and Nitish Dev.
Its last annual general meeting (AGM) was held on 11 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 69 Nirman Vihar Shakarpur, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.98 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹12.76 Lakh (net margin 37.5%) and EBITDA of ₹15.94 Lakh (EBITDA margin 46.9%). Revenue has grown at a compounded annual rate (CAGR) of 201% over three years and 98% over five years.
Company details
Contact details
DMVM Drugs Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA – 69 Nirman Vihar Shakarpur, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of DMVM Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of DMVM Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of DMVM Drugs Private Limited
FY 2025 filings availableDMVM Drugs Private Limited reported revenue of ₹33.98 Lakh (up 2420% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 98% over five years. EBITDA rose 767% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 46.9% | ||||
| Net Profit Margin | 37.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of DMVM Drugs Private Limited, buy the company report.
Board of directors of DMVM Drugs Private Limited
DMVM Drugs has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Molina Dev Also directs: NJD Spices Private Limited, NJD Ayurvedic Products Private Limited, Devpriya Polymers Private Limited and 5 more | Director | 09 Oct 2019 | 7 Years 1 Months | Current |
| Nitish Dev Also directs: Devpriya Polymers Private Limited, Dev Infrastructure Private Limited, Radha Swamy Realtors Private Limited and 2 more | Director | 16 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
DMVM Drugs Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alixion Pharmaceuticals India Private Limited | ₹34.21 Lakh (FY 2025) | 63.0% | Sonipat, Haryana, India | |||
| Zeylanica Pharmaceuticals Private Limited | ₹34.05 Lakh (FY 2025) | 9.0% | Vadodara, Gujarat, India | |||
| DMVM Drugs Private Limitedthis company | ₹33.98 Lakh (FY 2025) | ₹12.76 Lakh | 37.5% | 2420.0% | Delhi, India | |
| Adhisvar Pharmaceuticals Private Limited | ₹33.85 Lakh (FY 2025) | -6.0% | Vadodara, Gujarat, India |
To see the full peer comparison of DMVM Drugs Private Limited, buy the company report.
Auditor
DMVM Drugs Private Limited is audited by M.B. GUPTA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.B. GUPTA & CO. | FY 2023 | 006928N |
Shareholding
The shareholding of DMVM Drugs Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of DMVM Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving DMVM Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for DMVM Drugs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for DMVM Drugs Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
DMVM Drugs Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Nitish Dev was appointed as Director on 16 Apr 2024.
Frequently asked questions
DMVM Drugs is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2019 (7+ years old) and is registered under CIN U24297DL2019PTC356003.
DMVM Drugs has 2 current directors:
- Molina Dev - Director
- Nitish Dev - Director
The latest financial statements of DMVM Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 11 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of DMVM Drugs is U24297DL2019PTC356003. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DMVM Drugs was incorporated on 09 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of DMVM Drugs by revenue are Alixion Pharmaceuticals India Private Limited, Zeylanica Pharmaceuticals Private Limited, Adhisvar Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nitish Dev was appointed as Director on 16 Apr 2024. Priya Dev ceased to be Director on 16 Apr 2024. Molina Dev was appointed as Director on 09 Oct 2019. DMVM Drugs has 4 board changes on record in total.
The registered office of DMVM Drugs is at A – 69 Nirman Vihar Shakarpur, Delhi, India – 110092.
DMVM Drugs operates in the pharma industry, in the drug formulation and development segment.
DMVM Drugs can be reached at its registered office: A – 69 Nirman Vihar Shakarpur, Delhi, India – 110092.
DMVM Drugs is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
